Determinants of plasma platelet-activating factor acetylhydrolase: Heritability and relationship to plasma lipoproteins

Journal of Lipid Research

Volumn 38, Issue 11, 1997, Pages 2281-2288

  Guerra, Rudy ^c   Zhao, Biren ^a   Mooser, Vincent ^a   Stafforini, Diana ^d   Johnston, John M ^a   Cohen, Jonathan C ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c SOUTHERN METHODIST UNIVERSITY   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Familial hypercholesterolemia; Familial hypobetalipoproteinemia; Lovastatin; Low density lipoprotein

Indexed keywords

HYDROLASE; MEVINOLIN; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPOBETALIPOPROTEINEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AGE FACTORS; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERLIPOPROTEINEMIA TYPE II; HYPERLIPOPROTEINEMIA TYPE IV; HYPOBETALIPOPROTEINEMIAS; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, LDL; LOVASTATIN; MALE; PEDIGREE; PHOSPHOLIPASES A; REGRESSION ANALYSIS; SEX FACTORS;

EID: 0030699106     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Snyder, F. 1995. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes [published erratum appears in Biochim. Biophys. Acta. 1995. 1257:297]. [Review]. Biochim. Biophys. Acta. 1254: 231-249.
2. Imaizumi, T. A., D. M. Stafforini, Y. Yamada, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1995. Platelet-activating factor: a mediator for clinicians. [Review]. J. Int. Med. 238: 5-20.
3. Stafforini, D. M., S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1996. Mammalian platelet-activating factor acetylhydrolases. [Review]. Biochim. Biophys. Acta. 1301: 161-173.
4. Narahara, H., and J. M. Johnston. 1993. Smoking and preterm labor: effect of a cigarette smoke extract on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages. Am. J. Obstet. Gynecol. 169: 1321-1326.
5. Narahara, H., and J. M. Johnston. 1993. Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidnal macrophages. Am. J. Obstet. Gynecol. 169: 531-537.
6. Dupuis, F., Y. Denizot, P. Fixe, C. Dulery, and V. Praloran. 1996. PAF and haematopoiesis. X. Macrophage colony-stimulating factor and granulocyte macrophage colony-stimulating factor enhance platelet-activating factor acetylhydrolase production by human blood-derived macrophages. Biochim. Biophys. Acta. 1311: 27-32.
7. Pellon, M. I., S. Fernandez-Gallardo, M. A. Gijon, M. C. Garcia, F. T. Liu, and M. Sanchez Crespo. 1993. Effect of immunological stimulation on the production of platelet-activating factor by rat peritoneal cells: its relevance to anaphylactic reactions. Immunopharmacology. 26: 73-82.
8. Narahara, H., I. Miyakawa, and J. M. Johnston. 1995. The inhibitory effect of 1,25-dihydroxyvitamin D3 on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages. J. Clin. Endocrinol. Metab. 80: 3121-3126.
9. Stafforini, D. M., T. M. McIntyre, M. E. Carter, and S. M. Prescott. 1987. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J. Biol. Chem. 262: 4215-4222.
10. Ostermann, G., G. M. Kostner, A. Gries, E. Malle, and U. Till. 1989. The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum. Haemostasis. 19: 160-168.
11. Tew, D. G., C. Southan, S. Q. Rice, G. M. Lawrence, H. Li, H. F. Boyd, K. Moores, I. S. Gloger, and C. H. Macphee. 1996. Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 16: 591-599.
12. Carter, E., L. Wu, D. M. Stafforini, S. C. Hunt, R. R. Williams, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 1988. Platelet-activating factor acetylhydrolase correlates with plasma lipoproteins. Arteriosclerosis. 8: 712a.
13. Surya, I. I., M. Mommersteeg, D. W. Erkelens, and J. W. Akkerman. 1991. PAF-acetylhydrolase, predominantly present in LDL in healthy subjects, is associated with HDL in a patient with LDL deficiency. J Lipid Mediators. 3: 27-38.
14. Stafforini, D. M., M. E. Carter, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1989. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma. Proc. Natl. Acad. Sci. USA. 86: 2393-2397.
15. Steinbrecher, U. P., and P. H. Pritchard. 1989. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J. Lipid Res. 30: 305-315.
16. Stafforini, D. M., K. Satoh, D. L. Atkinson, L. W. Tjoelker, C. Eberhardt, H. Yoshida, T. Imaizumi, S. Takamatsu, G. A. Zimmerman, T. M. McIntyre, P. W. Gray, and S. M. Prescott. 1996. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase [see comments]. J. Clin. Invest. 97: 2784-2791.
17. Miwa, M., T. Miyake, T. Yamanaka, J. Sugatani, Y. Suzuki, S. Sakata, Y. Araki, and M. Matsumoto. 1988. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82: 1983-1991.
18. Farese, R. V., Jr., A. Garg, V. R. Pierotti, G. L. Vega, and S. G. Young. 1992. A truncated species of apolipoprotein B, B-83, associated with hypobetalipoproteinemia. J. Lipid Res. 33: 569-577.
19. Falconer, D. S. 1989. Introduction to Quantitative Genetics. Longman Group, Harlow, UK. 148 pp.
20. 2. Clin. Chem. 29: 2026-2030.
21. Blencowe, C., A. Hermetter, G. M. Kostner, and H. P. Deigner. 1995. Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein [a] in comparison with low density lipoprotein. J. Biol. Chem. 270: 31151-31157.
22. Goldstein, J. L., H. H. Hobbs, and M. S. Brown. 1995. Familial hypercholesterolemia. In The Metabolic and Molecular Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 1981-2030.
23. Linton, M. F., R. V. Farese, Jr., and S. G. Young. 1993. Familial hypobetalipoproteinemia. [Review]. J. Lipid Res. 34: 521-541.
24. Bilheimer, D. W., S. M. Grundy, M. S. Brown, and J. L. Goldstein. 1983. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc. Natl. Acad. Sci. USA. 80: 4124-4128.
25. Stafforini, D. M., G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1992. The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein. Trans. Assoc. Am. Phys. 105: 44-63.
26. Aguilar-Salinas, C. A., P. H. Barrett, K. G. Parhofer, S. G. Young, D. Tessereau, J. Bateman, C. Quinn, and G. Schonfeld. 1995. Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B. Arterioscler. Thromb. Vasc. Biol. 15: 71-80.
27. Sigurdsson, G., A. Nicoll, and B. Lewis. 1977. Turnover of apolipoprotein-B in two subjects with familial hypobetalipoproteinemia. Metab. Clin. Exp. 26: 25-31.
28. Bilheimer, D. W., S. Eisenberg, and R. I. Levy. 1972. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim. Biophys. Acta. 260: 212-221.
29. Eisenberg, S., D. W. Bilheimer, R. I. Levy, and F. T. Lindgren. 1973. On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. Biochim. Biophys. Acta. 326: 361-377.